Literature DB >> 14704882

An evaluation of the clinical utility of the OPIE-3 as an estimate of premorbid WAIS-III FSIQ.

Mike R Schoenberg1, Kevin Duff, James G Scott, Russell L Adams.   

Abstract

The clinical utility of the Oklahoma Premorbid Intelligence Estimate--3 (OPIE-3; Schoenberg, Scott, Duff, & Adams, 2002) in estimating premorbid FSIQ was investigated with the WAIS-III standardization sample. The OPIE-3 algorithms combine Vocabulary, Information, Matrix Reasoning, and Picture Completion subtest raw scores with demographic variables to predict FSIQ. Estimated WAIS-III FSIQ scores are presented for patients' diagnosed with dementia, traumatic brain injury, Huntington's disease, Korsakoff's disease, chronic alcohol use, temporal lobectomy, and schizophrenia. A group of patients with depression was employed as a clinical control group. The OPIE-3V and OPIE-3MR algorithms performed well, with the average predicted FSIQ of the combined clinical sample approximating the mean FSIQ of healthy adults. The OPIE-3(Best), which is a procedure that employs either the OPIE-3V, OPIE-3MR, or OPIE-3(2ST) algorithms in a best performance method, is presented. Recommendations in the application of the OPIE-3 are made and future research is proposed.

Entities:  

Mesh:

Year:  2003        PMID: 14704882     DOI: 10.1076/clin.17.3.308.18088

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  4 in total

1.  Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest.

Authors:  Justin J F O'Rourke; William H Adams; Kevin Duff; Joanne Byars; Peg Nopoulos; Jane S Paulsen; Leigh J Beglinger
Journal:  Arch Clin Neuropsychol       Date:  2010-12-08       Impact factor: 2.813

2.  Individual differences in spatial pattern separation performance associated with healthy aging in humans.

Authors:  Shauna M Stark; Michael A Yassa; Craig E L Stark
Journal:  Learn Mem       Date:  2010-05-21       Impact factor: 2.460

3.  Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects.

Authors:  Matthew J Smith; Derin J Cobia; James L Reilly; Jodi M Gilman; Andrea G Roberts; Kathryn I Alpert; Lei Wang; Hans C Breiter; John G Csernansky
Journal:  Hippocampus       Date:  2015-03-11       Impact factor: 3.899

4.  IQ estimate smackdown: comparing IQ proxy measures to the WAIS-III.

Authors:  Ruth Spinks; Lowell W McKirgan; Stephan Arndt; Kristin Caspers; Rebecca Yucuis; Christopher J Pfalzgraf
Journal:  J Int Neuropsychol Soc       Date:  2009-07       Impact factor: 2.892

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.